Eli Lilly (LLY) Stock: Key Catalysts to Watch Before the Market Opens on December 8, 2025
As Wall Street heads into Monday’s session, Eli Lilly and Company (NYSE: LLY) sits at the center of several big storylines: Chinese market access for its Alzheimer’s drug, a fresh FDA decision and new data for cancer therapy Jaypirca, price cuts for blockbuster obesity drug Zepbound, and a wave of institutional positioning. Below is a structured look at what matters for Eli Lilly stock before the U.S. market opens on Monday, December 8, 2025. 1. Where LLY Stock Stands After a Choppy Week In short, LLY heads into Monday as a mega‑cap growth stock that has cooled slightly but still